Feature Image: Photo by ThisisEngineering on Unsplash...
Feature Image: https://images.unsplash.com/photo-1507146153580-69a1fe6d8aa1?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3w3ODQzODd8MHwxfHJhbmRv...
title: "Quantum Threat Accelerates: Google Warns Bitcoin Cryptography Vulnerable in 9 Minutes" feature_image: "https://images.unsplash.com/photo-16690...
In a move that's shaking the robotics world, Physical Intelligence—the San Francisco startup that calls itself "ChatGPT for robots"—is reportedly in t...
Amazon just made its boldest move into consumer robotics yet, acquiring Fauna Robotics and its "approachable" humanoid robot Sprout. The deal, confirm...
Databricks just repriced 40% higher to $188 billion in seven months — a ~$3B round led by Coatue, still stubbornly private, and quietly running the AI economy's plumbing.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Developer documentation is the silent killer of product adoption. A 2025 study by the Developer Marketing Alliance found that 67% of developers will a...
Vera Therapeutics just won FDA accelerated approval for TRUTAKNA, the first dual BAFF/APRIL inhibitor for IgA nephropathy — priced at $425,000 a year. Here's why the two-target bet matters.
Feature Image: https://images.unsplash.com/photo-1648792940059-3b782a7b8b20?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3w3ODQzODd8MHwxfHNlYXJj...
BREAKING NEWS — In a move that signals the pharmaceutical industry's full-scale embrace of artificial intelligence, Swiss healthcare giant Roche has ...
